Abstract | BACKGROUND: OBJECTIVE: DESIGN: We studied 4584 participants with a mean (+/-SD) age of 52.1 +/- 13.7 y in the National Heart, Lung, and Blood Institute Family Heart Study in a cross-sectional design. Participants' diets were assessed with a semiquantitative food-frequency questionnaire. For each sex, we created age- and energy-adjusted quintiles of linolenic acid, and we used logistic regression to estimate prevalent odds ratios for CAD. RESULTS: From the lowest to the highest quintile of linolenic acid, the prevalence odds ratios of CAD were 1.0, 0.77, 0.61, 0.58, and 0.60 for the men (P for trend = 0.012) and 1.0, 0.57, 0.52, 0.30, and 0.42 for the women (P for trend = 0.014) after adjustment for age, linoleic acid, and anthropometric, lifestyle, and metabolic factors. Linoleic acid was also inversely related to the prevalence odds ratios of CAD in the multivariate model (0.60 and 0.61 in the second and third tertiles, respectively) after adjustment for linolenic acid. The combined effect of linoleic and linolenic acids was stronger than the individual effects of either fatty acid. CONCLUSIONS: A higher intake of either linolenic or linoleic acid was inversely related to the prevalence odds ratio of CAD. The 2 fatty acids had synergistic effects on the prevalence odds ratio of CAD.
|
Authors | L Djoussé, J S Pankow, J H Eckfeldt, A R Folsom, P N Hopkins, M A Province, Y Hong, R C Ellison |
Journal | The American journal of clinical nutrition
(Am J Clin Nutr)
Vol. 74
Issue 5
Pg. 612-9
(Nov 2001)
ISSN: 0002-9165 [Print] United States |
PMID | 11684529
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- alpha-Linolenic Acid
- Linoleic Acid
|
Topics |
- Coronary Artery Disease
(epidemiology, etiology, prevention & control)
- Cross-Sectional Studies
- Drug Synergism
- Female
- Humans
- Linoleic Acid
(administration & dosage, therapeutic use)
- Male
- Middle Aged
- Odds Ratio
- Prevalence
- Regression Analysis
- Risk Factors
- Surveys and Questionnaires
- United States
(epidemiology)
- alpha-Linolenic Acid
(administration & dosage, therapeutic use)
|